2019年4月2日
Combination of anti-IL-6 and anti-PD-L1 antibodies synergistically reinvigorates a potent cancer immunity by activating both CTL and Th1 cells in mice.
The American Association for Cancer Research (AACR) Annual Meeting 2019, Georgia World Congress Center, Atlanta, GA, U.S.A..
- 記述言語
- 英語
- 会議種別
- ポスター発表